CDK4/6 inhibitors in low-grade serous ovarian carcinoma (LGSOC): a pooled analysis

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Jasmina Veta Darkovski

DOI: 10.1016/j.ijgc.2025.103983

Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Advanced Breast Cancer Therapies PARP inhibition in cancer therapy